오픈뉴스백과
오늘의 이슈오늘 10장그래프ONP 브리핑
뉴스개체 사전회사공식 자료라이브용어사전뉴스로 배우기홈피드 제보내 편향
...

오픈뉴스백과

집단지성 기반 뉴스 검증 플랫폼. 다양한 시각으로 뉴스를 이해합니다.

서비스

오늘의 이슈홈라이브뉴스공식 자료용어사전소개

법적 고지

개인정보처리방침이용약관콘텐츠 이용 안내

문의

문의하기

본 플랫폼에서 제공하는 뉴스 콘텐츠의 저작권은 각 언론사에 있으며, 무단 복제 및 배포를 금지합니다.

RSS 피드를 통해 수집된 콘텐츠는 각 원저작자의 라이선스 조건을 따릅니다. 오픈 라이선스(CC-BY 등) 콘텐츠는 해당 라이선스에 따라 출처를 표기합니다.

오픈뉴스백과는 뉴스 집계 및 검증 플랫폼으로, 개별 기사의 내용에 대한 책임은 해당 언론사에 있습니다.

이용자가 작성한 피드백, 팩트체크, 독자 제보 등의 콘텐츠에 대한 책임은 해당 작성자에게 있습니다.

콘텐츠 제거·정정이 필요하시면 문의하기에 남겨 주세요.

© 2026 오픈뉴스백과 (OpenNewsPedia). All rights reserved.

뉴스 목록
관련 뉴스4건4개 미디어
진보 성향 33%중도 성향 33%보수 성향 34%
New York Post
진보 성향 33%중도 성향 33%보수 성향 34%
UK Government News
Global News (Canada)
Jordan News
New York Post
정부
기타

No Summer Shortcut for Safe Weight Loss

UK Government News
OGL v3.0
이 매체는 공공·자유 라이선스로 본문을 직접 표시합니다.

No Summer Shortcut for Safe Weight Loss
Healthy weight loss takes time, not shortcuts. As demand for weight-loss medicines continues to rise, the MHRA is reminding people how to use GLP-1 medicines safely, spot illegal sellers and avoid diet changes that could interfere with their medicines.
With prescription weight loss medicines being advertised illegally on social media alongside quick-fix slimming claims, the Medicines and Healthcare products Regulatory Agency (MHRA), warns Brits to not let summer slimming put their health at risk.
From over-dosing on prescription weight-loss meds to buying dangerous fakes online, the MHRA reveals the mistakes that could leave you seriously ill, and the simple steps to lose weight safely.
1. Follow doctor’s orders if you are prescribed a GLP-1
If you’ve been prescribed a GLP-1 weight-loss medicine, don’t be tempted to fast-track your weight loss by upping your dose. Semaglutide (Wegovy), tirzepatide (Mounjaro) and liraglutide (Saxenda) should only be taken as prescribed by a healthcare professional.
Follow doctors’ orders and take your prescribed GLP-1 alongside a healthy diet and a fitness regime. Whether you’re taking it for diabetes management or weight loss, maintaining good nutrition and exercise can help support muscle, bone, and overall health as your calorie intake changes.
2. Steer Clear of Fake Weight-Loss Meds
If you’re not eligible for a prescription for weight-loss medicines, don’t be tempted to buy them from unregulated websites or social media sellers. GLP-1 medicines authorised in the UK have only been shown to be safe and effective for people with a Body Mass Index (BMI) of 27 or more. Buying from rogue sellers is a huge risk. You can’t be sure what’s in the product, and some fake medicines are contaminated with toxic substances.
Don’t be tempted by the online hype around retatrutide. It has not been authorised for use in the UK, meaning anyone selling this product is doing so illegally. These products haven’t been tested for safety, quality or effectiveness and there’s no guarantee that they even contain retatrutide. You could be putting your health at serious risk.
Head of the MHRA’s Criminal Enforcement Unit, Andy Morling, said:
“Rogue sellers are driven by profit, not your safety, and the fake medicines they sell could put your health at serious risk. These products may not contain the GLP-1 medicine you think you’re buying and could be contaminated with bacteria and other harmful substances.
“Be wary of deals that seem too good to be true and check the pharmacy is registered with the General Pharmaceutical Council. The simple rule for staying safe is that if you’re offered a GLP-1 medicines without the need for a prescription – walk away.”
3. Check Your Meds Before Changing Your Diet
Trying to eat more healthily before your holiday? Great - but make sure your diet doesn’t clash with your medication. Always read the patient information leaflet before making dietary changes, as some foods could compromise medicines’ effectiveness. People taking simvastatin to lower their cholesterol should avoid grapefruit and grapefruit juice as they slow the rate the body breaks down the medicine, increasing the risk of serious side effects.
Thinking about intermittent fasting? Remember that some medicines need to be taken with food to work most effectively and lower your risk of side effects. Metformin, used to treat diabetes, and the painkiller naproxen should both be taken with or after food to help prevent stomach upset.
MHRA’s Chief Safety Officer, Alison Cave said:
“There’s no shortcut to safe weight loss. If you’re trying to slim down, follow medical advice, avoid fake medicines and remember that healthy eating and regular exercise are still the safest ways to get in shape for summer.”
Notes to editors:
-
The Medicines and Healthcare products Regulatory Agency (MHRA) is responsible for regulating all medicines and medical devices in the UK by ensuring they work and are acceptably safe. All our work is underpinned by robust and fact-based judgements to ensure that the benefits justify any risks.
-
The MHRA is an executive agency of the Department of Health and Social Care.
-
For media enquiries, please contact the newscentre@mhra.gov.uk, or call on 020 3080 7651.

전문 보기

이 뉴스, 어떠셨어요?

탭 한 번으로 반응 · 로그인 불필요

공식 발표 ↔ 진영별 보도

진보 성향 33%중도 성향 33%보수 성향 34%
1건1건1건
공식 발표 (1건) — 공공 라이선스 원문 직접 열람
진보 성향1
중도 성향1
보수 성향1
관련 뉴스 제보는 로그인 후 가능합니다.

'government' 카테고리 뉴스

Prime Minister’s opening remarks to staff following his arrival at No 10 North: 24 July 2026

UK Government News

Historic tariff-free Scotch whisky shipment bound for United States

UK Government News

Mock trial builds understanding of civil litigation process

UK Government News

UK Government의 다른 기사

Operation Unite: Nationwide crackdown marks new phase in fight against waste crime

UK Government News

UK takes command of multinational force for Ukraine

UK Government News

Looking behind the badge on International Security Officers’ Day

UK Government News

피드백

피드백을 남기려면 로그인해 주세요.

🇬🇧UK Government News
보는 중

No Summer Shortcut for Safe Weight Loss

🇨🇦Global News (Canada)

Hair loss risk goes up on GLP-1 drugs, BMJ study finds

🇯🇴Jordan News

Weight-Loss Drugs and Hair Loss: What Did the Latest Study Find?

🇺🇸New York Post

New studies reveal rare but real risk of GLP-1 drugs